Market Overview - In July, the A-share market experienced an overall upward trend, with the Shanghai Composite Index rising by 3.74%, the Shenzhen Component Index increasing by 5.20%, and the ChiNext Index gaining 8.14% by the end of July [1] Top Performing Stocks - The top-performing stock in July was Shangwei New Materials, which saw a staggering increase of 1083.42%, making it the first stock to achieve a tenfold increase in A-shares since 2025 [3][6] - Guangshengtang ranked second with a monthly increase of 218.94%, driven by significant progress in its hepatitis B innovative drug development [3][7] - Hengli Drilling Tools achieved a monthly increase of 191.24%, boosted by the commencement of a major hydropower project in the Yarlung Tsangpo River basin [3][9] Detailed Stock Performance - **Shangwei New Materials**: - The stock price surged from 9.34 yuan to 92.07 yuan between July 9 and July 30, with 11 trading days experiencing a 20% limit up [6] - The surge was attributed to an announcement regarding a significant acquisition that would change the controlling shareholder [6] - The company reported a net profit of 88.68 million yuan for 2024, a year-on-year increase of 25.01% [6] - **Guangshengtang**: - The stock had two trading days with a 20% limit up, with a total increase of 218.94% for the month [7] - The company received ethical review approval for its phase III clinical trial of GST-HG141 and had another drug, GST-HG131, recognized as a breakthrough therapy [7][8] - Guangshengtang has been a key player in the antiviral and liver disease sectors for over 20 years [8] - **Hengli Drilling Tools**: - The stock experienced three trading days with a 30% limit up, culminating in a 191.24% increase for the month [9] - The rise was linked to the launch of a significant hydropower project with an investment of approximately 1.2 trillion yuan [9] - Hengli specializes in the research, manufacturing, and sales of various drilling tools for construction projects [9]

Core Viewpoint - The A-share market experienced a strong performance in July, with major indices reaching new highs and significant sector gains, particularly in steel and pharmaceuticals [4][10]. Market Performance - The A-share market's total market capitalization increased to 104.48 trillion yuan, a monthly rise of 4.43 trillion yuan [2]. - The financing balance in the A-share market reached 1.9706 trillion yuan, marking a ten-year high, with a net inflow of 132.446 billion yuan in July [2]. Sector Performance - In July, the steel industry led the gains with an increase of 16.76%, followed by pharmaceuticals at 13.93% and construction materials at 13.36% [6][4]. - A total of 31 sectors saw positive performance, with only banking, utilities, and transportation sectors experiencing declines [4][6]. Top Performing Stocks - In July, 3,640 stocks had positive returns, with over 60% of stocks rising, 449 stocks gaining over 20%, and 84 stocks increasing by more than 50% [7]. - The top-performing stock, Upwind New Materials, surged by 1,083.42%, with its market capitalization growing from 3.138 billion yuan to 37.14 billion yuan [8][7]. Future Outlook - Analysts suggest that the A-share market may continue to trend upward in August, with equity market valuations remaining attractive compared to risk-free rates [10]. - Investment strategies should focus on growth technology sectors and companies with strong earnings support or exceeding expectations in their mid-year reports [11].

Macro Dynamics - The State Administration for Market Regulation will convert the pilot commission into a formal commission for conducting antitrust reviews of certain operator concentrations from August 1, 2025, after a successful pilot period from August 1, 2022, to July 31, 2025 [1] Financial Institutions - Zheng Yu has officially taken on the roles of Party Secretary, Chairman, and General Manager of Wukuang Securities, having previously served in various positions within the company [5] - Qingdao Bank reported a net profit of 3.065 billion yuan for the first half of 2025, representing a year-on-year increase of 16.05%, with total operating income of 7.662 billion yuan, up 7.5% [6] Market Data - On July 31, the three major indices fell by over 1%, with the Shanghai Composite Index down 1.18%, the Shenzhen Component Index down 1.73%, and the ChiNext Index down 1.66%. The total market turnover approached 2 trillion yuan, with over 4,200 stocks declining [7] - The financing balance of the two markets increased by 2.168 billion yuan, with the Shanghai Stock Exchange's balance at 1,001.228 billion yuan and the Shenzhen Stock Exchange's balance at 963.026 billion yuan [9] Company Dynamics - Industrial Fulian announced that there have been no significant changes in its main customers and products amid recent stock price fluctuations [13] - Sinopec expects a net profit of 20.1 billion to 21.6 billion yuan for the first half of 2025, a decrease of 39.5% to 43.7% year-on-year, due to factors such as a significant drop in international oil prices and intense market competition [14] - Heng Rui Medicine received approval for clinical trials of HRS-5041, a new drug for prostate cancer treatment, which shows potential in overcoming resistance compared to second-generation AR inhibitors [16]

Core Viewpoint - The A-share market experienced a decline on July 31, with all three major indices falling over 1%, while Huawei-related stocks saw significant gains, indicating a strong market reaction to Huawei's new AI cloud services launch [2] Group 1: Market Performance - On July 31, the A-share market saw a full-day adjustment, with all three major indices dropping more than 1% [2] - *ST Guangdao surged by 29.94%, leading the market, while other stocks like Siquan New Materials, Digital Certification, and Yidian Tianxia all hit the daily limit of 20% [2] - A total of 11 stocks related to Huawei reached their daily limit, showcasing a strong sector performance [2] Group 2: Huawei's New Launch - At the WAIC event, Huawei showcased its 384 super node hardware and the new generation Ascend AI cloud service based on CloudMatrix 384 super nodes [2] - The new AI cloud service is fully operational in data centers located in Wuhu, Gui'an, Ulanqab, and Ling'er [2]

Market Performance - On July 31, major indices experienced a downward trend, with the Shanghai Composite Index falling by 1.18%, the Shenzhen Component Index down by 1.73%, and the ChiNext Index decreasing by 1.66% [1] - The market saw a total trading volume of nearly 2 trillion yuan, with over 4,200 stocks declining [1] Sector Performance - Sectors that faced significant declines included coal, steel, shipping, oil, chemical fiber, real estate, non-ferrous metals, securities, insurance, aquatic products, and lithium mining [1] - Conversely, the pharmaceutical sector showed strength, with stocks like Nanjing New Pharmaceutical and Anke Bio reaching their daily limit [1] - The assisted reproduction concept and related stocks, such as A-share Gongtong Pharmaceutical and Lide Man, also saw substantial gains, with several stocks hitting their daily limit [6][8] Regulatory and Company News - *ST Guandao announced its stock would resume trading on July 31, 2025, amid risks of being forced to delist due to significant legal violations [3] - The company was under investigation by the China Securities Regulatory Commission (CSRC) since December 4, 2024, and received a notice of administrative penalty on June 13, 2025 [3] Policy Developments - The Beijing Municipal Government issued measures to enhance reproductive health services, including optimizing maternal and child healthcare resources and improving prenatal and postnatal care [8] - As of June 2025, 253 million people participated in maternity insurance, with total fund expenditures reaching 438.3 billion yuan [8] Gold Market Insights - The U.S. Federal Reserve maintained the federal funds rate target range at 4.25% to 4.50% [9] - In the first half of 2025, China's gold jewelry consumption decreased by 26%, while investment demand for gold bars and coins increased by 23.69% [9]

Market Overview - On July 31, major indices experienced a downward trend, with the Shanghai Composite Index falling by 1.18%, the Shenzhen Component Index down by 1.73%, and the ChiNext Index decreasing by 1.66% [1] - The market saw significant declines in sectors such as coal, steel, shipping, oil, chemical fiber, real estate, non-ferrous metals, securities, insurance, aquatic products, and lithium mining [1] - The total market turnover approached 2 trillion yuan, with over 4,200 stocks declining [1] Individual Stocks - Notably, *ST Guangdao, which resumed trading, hit the daily limit up, marking a "30cm" surge after a series of previous limit-up days and a subsequent suspension for investigation [1] - The company faces the risk of being subjected to mandatory delisting due to significant legal violations, as indicated by the China Securities Regulatory Commission's investigation and prior notice of administrative penalties [1] Assisted Reproductive Technology Sector - The assisted reproductive technology sector saw a strong performance, with stocks like A-share Gongtong Pharmaceutical, Lide Man, and Anke Bio hitting the daily limit up [2] - The Beijing Municipal Government issued a notice to enhance reproductive health services and improve maternal and child healthcare resources, which is expected to boost the sector [2] - As of June 2025, 253 million people participated in maternity insurance, with cumulative fund expenditures reaching 438.3 billion yuan, benefiting over 96 million people [2] Precious Metals Sector - The precious metals index continued its downward trend, with significant declines in companies such as Guoyan Platinum and Zijin Mining, which fell by over 4% [3] - The U.S. Federal Reserve maintained the federal funds rate target range at 4.25% to 4.50%, impacting market sentiment [3] - In the first half of 2025, China's gold jewelry consumption decreased by 26%, while investment demand for gold bars and coins increased by 23.69%, indicating a shift in consumer behavior due to high gold prices [3]

Group 1 - The core point of the article highlights the dramatic stock performance of *ST Guandao, which experienced a "limit down" followed by a "limit up" within the same trading day, marking it as the first stock in the Beijing Stock Exchange history to exhibit such a phenomenon [1] - As of July 31, the stock opened at 6.6 yuan per share and reached a historical low of 2.4 yuan per share on June 23, resulting in a significant rebound with a price increase of 4.1 times from the historical low by the end of July 31 [1] - The company specializes in digital products and services for industrial enterprises, as well as digital talent training and research innovation platform services [1] Group 2 - The company is facing a delisting risk warning due to an "unable to express opinion" audit opinion on its 2024 annual report, which is set to take effect on April 29, 2025 [1]

Market Overview - On July 31, major indices experienced a downward trend, with the Shanghai Composite Index falling by 1.18%, the Shenzhen Component Index down by 1.73%, and the ChiNext Index decreasing by 1.66% [1] - The market saw significant declines in sectors such as coal, steel, shipping, oil, chemical fiber, real estate, non-ferrous metals, securities, insurance, aquatic products, and lithium mining [1] - The total market turnover approached 2 trillion yuan, with over 4,200 stocks declining [1] Individual Stock Performance - Notably, *ST Guandao, which resumed trading, hit the daily limit up, achieving a "30cm" ceiling price after previously being suspended for investigation [1][3] - In the assisted reproduction sector, stocks like A-share Gongtong Pharmaceutical, Lidiman, and Anke Bio all reached their daily limit up, indicating strong market interest [6] Policy and Regulatory Developments - The Beijing Municipal Government issued measures to enhance reproductive health services, including optimizing maternal and child healthcare resources and improving assisted reproductive technology [8] - As of June 2025, 253 million people participated in maternity insurance, with cumulative expenditures reaching 438.3 billion yuan, and 31 provinces included assisted reproduction projects in medical insurance reimbursement [8] Economic Indicators - The U.S. Federal Reserve maintained the federal funds rate target range at 4.25% to 4.50% following a two-day monetary policy meeting [9] - In the first half of 2025, China's gold jewelry consumption decreased by 26%, while investment demand for gold bars and coins increased by 23.69%, indicating a shift in consumer behavior due to high gold prices [9]

智通财经7月31日电，今日复牌的*ST广道尾盘涨停，走出30cm"地天板"行情，成交超2亿元，换手率超 51%，该股此前走出30cm5天4板，今早以跌停价开盘。 北交所*ST广道尾盘上演30cm"地天板" 成交超2亿元 ...

证券时报·数据宝统计，截至下午13:59，今日沪指跌0.68%，A股成交量1086.62亿股，成交金额15203.16 亿元，比上一个交易日增加3.93%。个股方面，1603只个股上涨，其中涨停52只，3698只个股下跌，其 中跌停2只。从申万行业来看，计算机、通信、电子等涨幅最大，涨幅分别为1.39%、0.92%、0.58%； 钢铁、房地产、有色金属等跌幅最大，跌幅分别为3.55%、2.72%、2.69%。（数据宝） 今日各行业表现（截至下午13:59） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） | 申万行业 | 行业涨跌（%） | 成交额（亿元） | 比上日（%） | 领涨（跌）股 | 涨跌幅（%） | | --- | --- | --- | --- | --- | --- | | 计算机 | 1.39 | 1447.52 | 25.24 | *ST广道 | 26.54 | | 通信 | 0.92 | 895.38 | 38.09 | 鼎通科技 | 10.33 | | 电子 | 0.58 | 2071.44 | 17.68 | N鼎佳 | 483.06 | | ...